Filed: 1/21/2025ACC: 0000950123-25-000395
📋 What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $146.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$146.33M
Total AUM (reported)
14.46M
Total Shares
Allocation by class
COMMON STOCK$80.47M55.0%
ORDINARY SHARES$65.86M45.0%
Portfolio Concentration
Top 3$130.27M89.0%
4–10$16.06M11.0%
Top 3 weight
89.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 14.46M
Sole
Full voting authority
14.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Centessa Pharmaceuticals plc
SOLEShares3.93M
TypeSH
Market value$65.86M
45.01%
Sole
3.93M
Shared
0.00
None
0.00
Tectonic Therapeutics, Inc.
SOLEShares1.03M
TypeSH
Market value$47.49M
32.46%
Sole
1.03M
Shared
0.00
None
0.00
Kyverna Therapeutics, Inc.
SOLEShares4.52M
TypeSH
Market value$16.92M
11.56%
Sole
4.52M
Shared
0.00
None
0.00
Dyne Therapeutics, Inc.
SOLEShares407.50K
TypeSH
Market value$9.60M
6.56%
Sole
407.50K
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$3.83M
2.62%
Sole
1.80M
Shared
0.00
None
0.00
Kronos Bio, Inc.
SOLEShares2.77M
TypeSH
Market value$2.63M
1.80%
Sole
2.77M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plcSOLE | Ordinary Shares | 3.93M | SH | $65.86M 45.01% | 3.93M | 0.00 | 0.00 |
Tectonic Therapeutics, Inc.SOLE | Common Stock | 1.03M | SH | $47.49M 32.46% | 1.03M | 0.00 | 0.00 |
Kyverna Therapeutics, Inc.SOLE | Common Stock | 4.52M | SH | $16.92M 11.56% | 4.52M | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common Stock | 407.50K | SH | $9.60M 6.56% | 407.50K | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $3.83M 2.62% | 1.80M | 0.00 | 0.00 |
Kronos Bio, Inc.SOLE | Common Stock | 2.77M | SH | $2.63M 1.80% | 2.77M | 0.00 | 0.00 |